# Study Evaluating the Effects of PSI-697 on Platelets in Subjects Who Smoke

> **NCT03860506** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PSI-697
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03860506
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04-01
- **Primary completion:** 2008-07-01
- **Final completion:** 2008-07-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03860506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03860506, "Study Evaluating the Effects of PSI-697 on Platelets in Subjects Who Smoke". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03860506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*